Departments of Receptor Biochemistry (G.C., C.W., K.Q., C.K.J.,
T.K.) and of Molecular Sciences (J.W., S.A., W.-J.C.), Glaxo Wellcome
Research and Development, Research Triangle Park, North Carolina
This article describes the behavior of transiently transfected human
receptors into melanophores and the potential use of constitutive
receptor activity to screen for new drug entities. Specifically,
transient transfection of melanophores with different concentrations of
receptor cDNA presumably leads to increased levels of receptor
expression. This leads to an increased response to agonists (both
maxima and potency) and, in some cases, an agonist-independent constitutive receptor activity. Transfections with increasing concentrations of the Gs protein-coupled human calcitonin
receptor type 2 (hCTR2) cDNA produced sufficient levels of
constitutively activated receptor to cause elevated basal cellular
responses. This was observed as a decrease in the transmittance of
light through melanophores (consistent with Gs protein
activation) and increased response to human calcitonin. The
receptor-mediated nature of this response was confirmed by its reversal
with the hCTR2 peptide inverse agonist AC512. A collection of ligands
for hCTR2 either increased or decreased constitutive hCTR2 activity, suggesting that the constitutive system was a sensitive discriminator of positive and negative ligand efficacy. Similar results were obtained
with Gi-protein-coupled receptors. Transient transfection of NPY1, NPY2, NPY4, CXCR4, and CCR5 cDNA produced increased light transmittance through melanophores (consistent with
Gi-protein activation). NPY1 cDNA produced little
constitutive response on transfection, whereas maximal levels of
constitutive activity ranging from 30 to 45% were observed for the
other Gi-protein-coupled receptors. Responses to agonists
for these receptors increased (both maxima and potency) with increasing
cDNA transfection. The receptor/Gi-protein nature of both
the constitutive and agonist-mediated responses was confirmed by
elimination with pertussis toxin pretreatment. These data are discussed
in terms of the theoretical aspects of constitutive receptor activity
and the applicability of this approach for the general screening of
G protein-coupled orphan receptors.
 |
Introduction |
High-throughput screening with
combinatorial chemical libraries is an effective method of discovery of
new ligands that interact with receptor targets. The interference of
receptor signals mediated by the interaction of the receptor with known
ligands is the common method of detection of new entities. In the case
of orphan receptors, for which there are still no known ligands, this
system is capable only of discovering excitatory (agonist) ligands that
cause receptor activation and thus a measurable signal.
G protein-coupled receptors (GPCRs) can spontaneously form active
states that subsequently can activate G proteins and thus produce a
measurable pharmacologic response (Costa and Herz, 1989
; Samama et al.,
1993
). Unless ligands have identical affinities for the different
activation states of seven transmembrane receptors present in
constitutive receptor systems, their binding will redistribute the
species, and this will be detected as either an increase or a decrease
in the constitutive receptor activity (see predictions of ternary
complex models describing this effect in Appendix I). There
are data to show that a measurable constitutive GPCR activity can be
obtained by receptor overexpression in recombinant systems (Appendix II; Kenakin, 1996
). Therefore, one approach to the
screening of GPCRs is to overexpress the receptor to the point of
observing constitutive activity and then allowing ligands with affinity
to redistribute the receptor species. The following are requirements
for such assays: 1) the receptor must have some proclivity to
spontaneously form an active state, 2) there must be suitable G
proteins available in the cell to interact with the active state, and
3) there must be a means to monitor the amount of activated G protein
(Kenakin, 1997
).
This article describes the study of constitutive receptor activity in
Xenopus laevis melanophores, cells that fulfill the second
and third prerequisites of the assay. Specifically, these cells contain
a wide range of G
proteins (Jayawickreme et al., 1994
);
therefore, the functional expression of numerous foreign GPCRs can be
facilitated (Potenza et al., 1992
, 1994
; Karne et al., 1993
; Graminski
et al., 1993
; McClintock et al., 1993
; Graminski and Lerner, 1994
;
Jayawickreme et al., 1994a
,b
; Lerner, 1994
). This system can be
monitored in real time by the dispersion and aggregation of melanin.
Melanosome dispersion can be affected via activation of adenylyl
cyclase (Potenza et al., 1992
; McClintock et al., 1993
) or
phospholipase C (Graminski et al., 1993
), whereas melanosome
aggregation results from the inhibition of adenylyl cyclase (Potenza et
al., 1992
; McClintock et al., 1993
). Because both states (dispersion or
aggregation) of intracellular melanosome distribution are easily
detectable, GPCRs can be studied by monitoring ligand-mediated
melanosome translocation by either measuring the change in light
transmittance through the cells or by imaging the cell response
(Potenza et al., 1992
, 1994
; Karne et al., 1993
; McClintock et al.,
1993
; Graminski et al., 1993
; Graminski and Lerner, 1994
; Jayawickreme
et al., 1994a
,b
; Lerner, 1994
).
 |
Experimental Procedures |
Materials.
Leibovitz (L-15) medium came from Sigma Chemical
Co. (St. Louis, MO), BSA from Boehringer Mannheim (Indianapolis, IN),
and pertussis toxin (PTX) from Calbiochem (516560; La Jolla, CA).
Construction of Expression Vectors.
The full-length cDNA for
human calcitonin receptor type 2 (hCTR2) (Chen et al., 1997
), NPY1,
NPY2, NPY4 (Matthews et al., 1997
), CX chemokine receptor type 4 (CXCR4), and chemokine C receptor 5 (CCR5) (Chen et al., 1998
) were
amplified by a reverse-transcriptase polymerase chain reaction strategy
as described. DNA fragments containing coding sequences were isolated
and subcloned into the melanophore expression vector pJG3.6 (Graminski
et al., 1993
). Plasmid DNA used for melanophore transfections was
prepared by a modification of the triton-lysozyme method and double
banded in CsCl/ethidium bromide equilibrium gradients as described
(Davis et al., 1994
).
Functional Bioassay.
Melanophores were maintained in cell
cultures as previously described (Jayawickreme et al., 1994a
,b
).
Transient expression of GPCR plasmid DNA in melanophores was achieved
after electroporation (Graminski et al., 1993
; Jayawickreme et al.,
1994
). After electroporation, cells were seeded into flat-bottom
96-well tissue culture plates (Falcon Labware, Oxnard, CA) to a density
of 20,000 cells/well in conditioned fibroblast medium (CFM) and
incubated at 27°C for 24 to 48 h. Nontransfected cells did not
respond to the agonists used in this study.
The ligand-mediated responses in recombinant melanophores were
monitored by measuring the change in transmittance with an SLT Spectra
plate reader (Hillsborough, NC). For an experiment, media was removed
from the plates and replaced with 0.7× L-15/0.1% BSA containing test
drugs. Soon after the addition of reagents, the zero time reading
(Ti) was obtained. The plates were then placed
in the dark and read at appropriate time intervals
(Tf). The extent of the response was quantified
(Jayawickreme et al., 1994a
; Potenza et al., 1994
) as (1
Tf/Ti).
In the studies with PTX, the transfected cells were incubated overnight
(16-18 h) in CFM with 1 µg/ml of PTX. Just before the assay, the
media was removed and replaced with 0.7× L-15/0.1% BSA containing
various reagents and/or drugs.
 |
Results |
Gs Protein-Coupled Receptor (hCTR2).
Transient
transfection of melanophores with cDNA for hCTR2 resulted in a
cDNA-dependent decreased light transmittance and the acquisition of
responses to human calcitonin (hCAL). Figure 1I shows the effect of transfection of
melanophores with 32 µg of cDNA for hCTR2. Also shown are the effects
of increasing concentrations of the inverse agonist AC512. The
reduction in the melanin dispersion by AC512 indicates that it was
caused by constitutive activation of Gs protein by the
transiently expressed receptor.

View larger version (184K):
[in this window]
[in a new window]
|
Fig. 1.
Constitutive activity in melanophores expressing
hCTR2 receptor. Melanophores were transfected with 32 µg of hCTR2
cDNA. A, effect of 1 µM AC512. B, effect of 100 nM AC512. C, effect
of 10 nM AC512. D, effect of 1 nM AC512. E, effect of 100 pM AC512. F,
effect of 10 pM AC512. G, effect of 1 pM AC512. H, effect of 0.1 pM
AC512. I, effect of no AC512.
|
|
Figure 2A shows the positive temporal
response to hCAL; equilibrium is attained within 60 to 90 min. The
temporal effects of the inverse agonist AC66 are shown in Fig. 2B. The
dose-response relationships for these effects are shown in Fig. 2C.

View larger version (22K):
[in this window]
[in a new window]
|
Fig. 2.
Temporal effects of agonists and inverse agonists on
melanophores transfected with 8 µg of hCTR2 cDNA. A, effects of 0.1 nM hCAL ( ), 1 nM ( ), and 10 nM ( ) with time. B, effect of the
inverse agonist AC66 at 1 nM ( ), 10 nM ( ), and 100 nM ( ) with
time. C, dose-response curves for hCAL and AC66.
|
|
Figure 3 shows the relationship of
dose-response curves to hCAL and the inverse agonist AC512 with
different levels of constitutive receptor activity. The elevated
baseline and dose-response curve to hCAL after transfection of cells
with 16 µg of cDNA are shown in Fig. 3A. Also shown in this figure is
the inverse agonism by the inverse agonist peptide AC512. Figure 3B
shows the effects of hCAL and AC512 in cells transfected with 32 µg
of cDNA; the constitutive basal response is greater in these cells.

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 3.
Effect of transfection with hCTR2 cDNA on basal
activity and response to hCAL ( ) and the inverse agonist AC512
( ). Cells transfected with 16 µg (A) and 32 µg (B) of hCTR2
cDNA.
|
|
The effects of a wider range of cDNA is shown in Fig.
4A. It can be seen from this figure that
increasing cDNA levels cause increasing constitutive activity, whereas
the maximal responses to hCAL increase to the level shown for 16 µg
of cDNA and progress no higher at 32 µg of cDNA. The location
parameters of the dose-response curves shift to the left as predicted
by the ternary complex model for GPCRs (see Appendix III).
Figure 4B shows the corresponding effects of increasing cDNA on the
inverse agonism with AC512. In this case, as predicted by theory, the
dose-response curves shift to the right with increasing constitutive
activity (Appendix III). The constitutive receptor activity
of hCTR2, as a function of receptor level, is shown in Fig.
5, along with the corresponding maximal
responses to hCAL. These data show that the maximal constitutive
activity was approximately 60% of the maximal possible response to the
full agonist hCAL.

View larger version (27K):
[in this window]
[in a new window]
|
Fig. 4.
Effects of different levels of hCTR2 transfection.
Dose-response curves to hCAL (A) and AC512 (B) in melanophores
transfected with hCTR2 cDNA in concentrations shown in legends to the
right of the graphs.
|
|

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 5.
Dependence of basal constitutive receptor activity
( ) and maximal response to hCAL ( ) on concentration of hCTR2 cDNA
used for transfection.
|
|
The effects of several agonists and antagonists for hCTR2 were tested
in a constitutive system resulting from transfection of melanophores
with 8 µg of cDNA for hCTR2 (structures of ligands shown in Table
1). As can be seen in Fig.
6, all the ligands tested produced either positive or
inverse agonism. A higher level of constitutive activity (16 µg of
cDNA) showed a similar profile for these agonists, except that the
maximal range for increases to the positive agonists was closer to the
basal level, leading to a diminished maximal delta response to these
agonists. In contrast, the maximal delta range for the inverse agonists
was increased (data not shown).

View larger version (27K):
[in this window]
[in a new window]
|
Fig. 6.
Effects of peptide calcitonin ligands for hCTR2 in
melanophores transfected with 8 µg of hCTR2 cDNA.
|
|
Gi Protein-Coupled Receptors.
Corresponding data
were collected for Gi-coupled receptors. Note that
activation of Gi protein causes increased light
transmittance, which, in turn, produces more negative values for
1
(Tf/Ti). Thus, unlike the
dose-response curves for activation of Gs protein, positive
agonism produces more negative values, and inverse agonism produces
increases in 1
(Tf/Ti)
values. Figure 7A shows the effects of
transient transfection with a range of concentrations of cDNA for human
CXCR4. As can be seen from this figure, increasing levels of cDNA
produces increased basal response and a corresponding increase in the
maximal response to a natural agonist for this receptor (SDF-1
). As
with hCTR2, the location parameters of the dose-response curves to
SDF-1
shift to the left with increasing receptor transfection level.
Figure 7B shows the effects of various levels of transfection on the
maximal response to SDF-1
and the basal activity. As with hCTR2, the
maximal constitutive activity is below that produced by the agonist.

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 7.
Effects of different levels of CXCR4 transfection on
responses to SDF-1 (A) and basal and maximal agonist response (B).
A, dose-response curves to SDF-1 in melanophores transfected with
CXCR4 cDNA at 10 µg ( ), 20 µg ( ), 40 µg ( ), and 80 µg
( ). B, dependence of basal constitutive receptor activity ( ) and
maximal response to SDF-1 ( ) on concentration of CXCR4 cDNA used
for transfection.
|
|
The association of the elevated basal response to constitutive CXCR4
activity was supported by the elimination of the effect with PTX.
Figure 8, A to D, shows the effects of
PTX pretreatment (1 µg/ml, 24 h) on the basal and
agonist-mediated responses to 20, 40, 80, and 100 µg of cDNA. As can
be seen from this figure, the elimination of Gi protein
function eliminates both the constitutive receptor activity and the
responses to SDF-1
.

View larger version (25K):
[in this window]
[in a new window]
|
Fig. 8.
Effects of PTX treatment on constitutive and
agonist-induced responses of melanophores transfected with CXCR4.
Responses to SDF-1 in melanophores not treated ( ) and treated
with PTX ( ). Melanophores transfected with 20 µg (A), 40 µg (B),
80 µg (C), and (D) 100 µg of CXCR4 cDNA.
|
|
Similar data were obtained for human CCR5. As seen in Figure
9A, transfection with increasing
concentrations of cDNA lead to increasing constitutive activity,
maximal response to MIP-1
, and decreasing EC50 for
MIP-1
responses. Figure 9B shows that, as for CXCR4, essentially the
lowest concentration of cDNA that causes receptor expression also shows
constitutive activity; i.e., there is no threshold expression level for
constitutive receptor activity. Both the constitutive and
agonist-induced responses after receptor expression were prevented by
pretreatment of cells with PTX.

View larger version (23K):
[in this window]
[in a new window]
|
Fig. 9.
Effects of different levels of CCR5 transfection on
responses to MIP-1 (A) and basal and maximal agonist response (B).
A, dose-response curves to MIP-1 in melanophores transfected with
CCR5 cDNA at 10 µg ( ), 20 µg ( ), 40 µg ( ), 80 µg
( ), and 160 µg ( ). B, dependence of basal constitutive receptor
activity ( ) and maximal response to MIP-1 ( ) on concentration
of CCR5 cDNA used for transfection.
|
|
Figure 10A shows corresponding data for
NPY1. In contrast to the previously discussed chemokine receptors, NPY1
showed very little, if any, constitutive receptor activity. Thus,
although transfection with 3, 10, 20, 40, and 80 µg of NPY1 cDNA lead
to receptor expression (as concluded by the presence of responses to
PYY), no consistent constitutive receptor activity was observed. The
responses to PYY at all levels of transfection were prevented by
pretreatment with PTX.

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 10.
Effects of different levels of NPY1 receptor
transfection on responses to PYY (A) and basal and maximal agonist
response (B). A, dose-response curves to PYY in melanophores
transfected with NPY1 cDNA at 10 µg ( ), 20 µg ( ), 40 µg
( ), and 80 µg ( ). B, dependence of basal constitutive receptor
activity ( ) and maximal response to PYY ( ) on concentration of
NPY1 cDNA used for transfection.
|
|
Figure 11A shows the increased
constitutive receptor activity and responsiveness to PYY produced by
transfection with increasing concentrations of NPY2 cDNA. As with
previous receptors, the maximal response and sensitivity to PYY
increased with increasing receptor transfection, but, in contrast to
previous receptors, a slight threshold phenomenon was observed. Thus,
transfection with 5 µg of cDNA produced receptor expression (as
concluded by observation of responses to PYY) but no concomitant
constitutive activity (Fig. 11B). Presumably, this is a consequence of
the magnitude of the receptor allosteric constant and stoichiometry of
the system (see Discussion). Responsiveness to PYY and
constitutive activity were prevented by pretreatment with PTX.

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 11.
Effects of different levels of NPY2 receptor
transfection on responses to PYY (A) and basal and maximal agonist
response (B). A, dose-response curves to PYY in melanophores
transfected with NPY2 cDNA at 5 µg ( ), 10 µg ( ), 20 µg
( ), 40 µg ( ), and 80 µg ( ). B, dependence of basal
constitutive receptor activity ( ) and maximal response to PYY ( )
on concentration of NPY2 cDNA used for transfection.
|
|
A similar pattern was observed for NPY4 (Fig.
12). Thus, transfection with increasing
concentrations of NPY4 cDNA leads to increased response and
responsiveness to PYY and constitutive activity with a small threshold
for constitutive activity. PTX pretreatment prevented these effects.

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 12.
Effects of different levels of NPY4 receptor
transfection on responses to PYY (A) and basal and maximal agonist
response (B). A, dose-response curves to PYY in melanophores
transfected with NPY4 cDNA at 5 µg ( ), 10 µg ( ), 20 µg
( ), 40 µg ( ), and 80 µg ( ). B, dependence of basal
constitutive receptor activity ( ) and maximal response to PYY ( )
on concentration of NPY4 cDNA used for transfection.
|
|
 |
Discussion |
The discovery of constitutive GPCR activity presented a
theoretical approach to the identification of ligands for orphan
receptors. The basic premise for this idea is that different tertiary
conformations of the receptor protein will display different binding
domains for ligands. Unless the affinities of the ligands for these
different domains were identical, they would bind to each conformation
according to mass action kinetics (the concentration of ligand and the
respective equilibrium dissociation constants for the ligand-receptor
conformation complex). The differential binding to these conformations
necessarily would change their relative abundance (see Appendix
I), and this redistribution necessarily would alter the
concentration of the signaling species, namely,
RaG (see Fig.
13). The magnitude of the observed
response depends on the amount of RaG species formed and the sensitivity of the stimulus-response machinery of the
cell. Theoretically, any sensitive functional assay (e.g., reporters,
yeast) could be used for constitutive screening. Melanophores were
chosen in this study because of the high sensitivity of the stimulus-response mechanisms for Gs, Gi, and
Gq in this cell line. Many GPCRs have been successfully
transiently expressed in these cells with concomitant observation of
Gi, Gs, and Gq activation. Finally,
note that responses in melanophores can be viewed in real time (see
Fig. 2), thereby allowing the direct observation of steady states.

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 13.
Two models of GPCR systems. A, extended ternary
complex model describing two receptor states (Ri
and Ra) whereby the active state
Ra interacts with G protein (G) (Samama et al.,
1993 ). B, the cubic ternary complex whereby both inactive and active
states of the receptor are allowed to interact with the G protein, but
only ARaG mediates response (Weiss et al.,
1996a ,b ).
|
|
The propensity of a given GPCR to form the active state is an inherent
property of the receptor. In terms of the ternary complex model, this
is defined by the allosteric constant (L in Fig. 13) as
[Ra]/[Ri]. Although there are
instances where this can be altered biochemically (i.e., removal of
Na+; Costa and Herz, 1989
; Tian et al., 1994
) for some
receptors, the usual method of creating a constitutively active
receptor system is to manipulate the stoichiometry of receptors and G
proteins. For example, constitutive activity has been observed with
increasing receptor expression (i.e.,
2-adrenoceptors;
Samama et al., 1993
; thyroid-stimulating hormone receptors; Van Sande
et al., 1995
) and enrichment of G proteins (Senogles et al., 1990
). The
rationale for this approach is that, because the allosteric constant
controls the fraction of receptors in the activated state, a critical
concentration of active receptors, for the creation of observable
response, can be obtained by simply increasing the number of receptors
expressed. The data obtained with the receptors in this study are
consistent with this idea but also highlight the uniqueness of
different types of receptors. Relatively high levels of constitutive
activity were attained with the Gi protein-coupled
receptors NPY2, NPY4, CXCR4, and CCR5; however, NPY1 was uniquely
quiescent and produced little observed constitutive activity at cDNA
levels that clearly allowed cell surface receptor expression (as
evidenced by the responses to the agonist PYY).
Note that the application of the models to the observed data tacitly
assumes that exposing the cells to increasing levels of receptor cDNA
leads to increasing receptor expression. However, this assumption is
not limiting to the use of constitutive activity for screening
purposes, because the transient transfection is titrated to a given
level of response regardless of the actual receptor density present on
the membrane.
If the host cell sensitivity to active-state receptor is low, then,
conceivably, high receptor transfection levels would be required before
sufficiently high levels of active receptor could spontaneously be
generated to produce visible response. In contrast, there would be much
less limitation on agonist-induced response, because saturating
concentrations of full agonist would lead to conversion of all existing
receptors into the active state. Under these circumstances, a threshold
phenomenon would be predicted in which receptor transfection would take
place (and response to agonist would be observed), but no constitutive
receptor activity would be observed until considerably greater levels
of receptor expression. Surprisingly, whereas a slight threshold effect
was observed in these studies for NPY2 and NPY4, essentially
constitutive receptor activity was observed with almost all levels of
receptor expression. This suggests that melanophores have high
responsiveness characteristic to GPCR activity, an idea supported by
the high sensitivity of agonists in this system.
Another interesting outcome of this study was the results of the
limited test of the notion that most ligands with affinity for any
given GPCR will have differential affinity for the various states of
the receptor and thus show a detectable response in the constitutively
active receptor system. As shown in Fig. 6, ligands known to bind to
hCTR2 either produced positive agonism or negative agonism; there were
no "neutral" antagonists in this collection of ligands. Although
this clearly is a limited sample, it is interesting that the data were
consistent with the thermodynamic prediction.
Two versions of the ternary complex model predict different degrees of
maximal constitutive receptor activity from GPCR systems (Appendix II). The extended ternary complex model predicts that the same maximal response that is produced by an agonist should be
observed constitutively with high receptor expression levels (if the
amount of receptor is not limiting). A different prediction is
consistent with the cubic ternary complex model, which allows for the
inactive state of the receptor to interact with G proteins.
Interestingly, antagonist-induced receptor/G protein interactions
leading to ternary complexes that do not signal
(ARiG complex in Fig. 13) have been reported for
MOR-1 (Brown and Pasternak, 1998
). Also, nonsignaling ternary complexes
with the inverse agonist SR 144528 have been reported for cannabinoid receptors (Bouaboula et al., 1997
, 1999
). If such nonsignaling complexes are formed, then this model predicts that a limit can be
reached where the maximal constitutive response will be lower than the
agonist-induced maximal response according to system parameters
describing the ability of the receptor to form the active state
(allosteric factor L) and the differential affinity of the
activated receptor (over the inactive state) for G proteins (
in
Fig. 13). As seen in Figures 5, 7, and 9 through 12, the maximal constitutive activity observed was substantially lower than the agonist-induced maximal response. Whereas this ostensibly indicates that the cubic model better describes GPCR systems, note that there is
no way of knowing whether the amount of receptor transfected into the
melanophores did not limit the maximal interaction between receptor and
G protein. Therefore, the submaximal constitutive receptor activity
does not furnish definitive evidence for nonsignaling receptor/G
protein complexes.
The data presented with these receptors indicate that a constitutive
GPCR assay is a viable alternative for screening orphan receptors. The
advantage of such an approach lies in the expanded window of detection.
Not only will agonists be found but also inverse agonists. This option
is not available in nonconstitutively active screens in which only
positive agonists will be detected. Another advantage of constitutive
screens is the fact that they can be more sensitive to agonists than
quiescent assays (Appendix III and Fig. 4). Theoretically,
this also applies to inverse agonists, although for these ligands
(where
and
< 1), the enhancing effects of constitutive
activity will be severely dampened so as to become nearly
insignificant. Interestingly, whereas an increased sensitivity to the
positive agonist human calcitonin was observed in this study (Fig. 4A),
little change in potency for the inverse agonist AC66 was seen (Fig.
4B), agreeing with this prediction.
The possible disadvantage of this assay is the added variability of
screening with transient transfections. The level of constitutive activity varies with the efficiency of receptor transfection, which, in
turn, affects the sensitivity of the assay to positive and negative
agonism (see Appendix III). It is difficult to predict, in
general terms, whether this variability is too high a cost for
constitutive screening. The key probably lies in the nature of the
receptor, the efficiency of receptor expression, the magnitude of the
allosteric constant L, and the host cell system (i.e.,
stoichiometry of the G proteins available for interaction with the
active-state receptor). In general, the main drawback to constitutive
systems would be the possibility of decreasing the positive scale for
potential agonism (i.e., the constitutive activity approaches the
endogenous agonist maximal response). With appropriate controls (i.e.,
the measurement of the maximal detectable levels of increased
Gs or Gi/Gq activation with
standard agonists), the control of constitutive receptor activity below these levels would be sufficient to ensure the possibility of detection
of positive agonists.
These data are consistent with the idea that constitutive GPCR systems
can be made sufficiently sensitive and stable to be used in screening
for ligands. The fact that all but one of the receptors we tested
provided substantial constitutive activity suggests that this approach
would be especially useful for the screening of orphan receptors.
 |
Appendices |
Certain predictions can be made from the extended ternary complex
(ETC) model as presented by Samama et al. (1993
; Fig. 13A)
and the cubic ternary complex (CTC) model (Weiss et al.,
1996a
,b
; Fig. 13B) about the relationship among receptor density,
constitutive response, sensitivity to ligands, and the ability to
discern receptor conformations. Note that the models described below
are binding models that do not take into account GTP activation of
the G protein, and, as such, they may not adequately describe
functional systems.
Differential affinities for different receptor conformations (as
found in constitutively active receptor systems) leads to enrichment of
the species for which the ligand has the highest affinity. This can be
illustrated with a system containing two receptor conformations
R and R* that coexist in the system according to
an allosteric constant denoted L'
hCTR2, human calcitonin receptor type 2;
GPCR, G protein-coupled receptor;
PTX, pertussis toxin;
CFM, conditioned
fibroblast medium;
hCAL, human calcitonin.